Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer.
Article Details
- CitationCopy to clipboard
Hutson PR
Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer.
Clin Pharmacokinet. 2015 Oct;54(10):989-91. doi: 10.1007/s40262-015-0293-z.
- PubMed ID
- 26077984 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Enzalutamide Cytochrome P450 2B6 Protein Humans NoInhibitorDetails